VAERS Explorer
Back to explore

Report #2837040

Received Apr 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
73 yrs
State
OK
Recovered
Not recovered
Vaccinated
Apr 10, 2025
Onset
Apr 11, 2025
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (4)

AstheniaChillsDiarrhoeaVomiting

Symptom narrative

vomiting; Diarrhea; Chills; Weakness; This non-serious case was reported by a consumer via call center representative and described the occurrence of vomiting in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 10-APR-2025, the patient received the 1st dose of Shingrix. On 11-APR-2025, 1 days after receiving Shingrix, the patient experienced vomiting (Verbatim: vomiting), diarrhea (Verbatim: Diarrhea), chills (Verbatim: Chills) and weakness (Verbatim: Weakness). The outcome of the vomiting, diarrhea, chills and weakness were not resolved. It was unknown if the reporter considered the vomiting, diarrhea, chills and weakness to be related to Shingrix. It was unknown if the company considered the vomiting, diarrhea, chills and weakness to be related to Shingrix. Additional Information: GSK Receipt Date: 11-APR-2025 The husband of the patient reports she received dose of Shingrix and next morning she woke up with chills, vomiting, diarrhea and weakness.